Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Kringle Pharma Inc (4884 JP)
Watchlist
1
Analysis
Health Care
•
Japan
Kringle Pharma, Inc. develops and distributes biotechnology products. The Company produces regenerative medicines, cancer therapy medicines, and other products. Kringle Pharma markets its products throughout Japan.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Kringle Pharma Inc
•
13 Aug 2024 08:00
•
Issuer-paid
Kringle Pharma Inc (4884 JP): Q3 FY09/24 flash update
**Q3 FY09/24 Financial Results:** Revenue JPY61mn (+19.3% YoY), operating loss JPY580mn, net loss JPY518mn, total assets JPY2.9bn. **Revised...
Shared Research
Follow
164 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.35.0
x